A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Selected Advanced Solid Tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512822-28-00

Acronym

INCB 123667-101

Enrollment

235

Registered

2024-06-21

Start date

2022-08-08

Completion date

Unknown

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or metastatic solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026